Skip to main content
user-generated· Science

Will Moderna and Merck announce the initiation of a Phase 3 clinical…

Market overview

Successful late-stage results in one indication often prompt pharmaceutical companies to explore the therapy's efficacy in other related conditions. Given the broad potential of cancer vaccines, expanding trials to new indications is a logical next step.

Science prediction market

Implied probability (Yes)
55%
Closes
2026-11-17

More Science markets

Browse all Science markets →

Loading…